Cargando…
Role of L2 cysteines in papillomavirus infection and neutralization
Vaccination of mice with minor capsid protein L2 or passive transfer with the L2-specific neutralizing monoclonal antibody RG-1 protects against human papillomavirus type 16 (HPV16) challenge. Here we explored the nature of the RG-1 epitope and its contribution to viral infectivity. RG-1 bound equiv...
Autores principales: | Gambhira, Ratish, Jagu, Subhashini, Karanam, Balasubramanyam, Day, Patricia M, Roden, Richard |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2772844/ https://www.ncbi.nlm.nih.gov/pubmed/19860897 http://dx.doi.org/10.1186/1743-422X-6-176 |
Ejemplares similares
-
Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines
por: Jagu, Subhashini, et al.
Publicado: (2009) -
Optimization of Multimeric Human Papillomavirus L2 Vaccines
por: Jagu, Subhashini, et al.
Publicado: (2013) -
Capsomer Vaccines Protect Mice from Vaginal Challenge with Human Papillomavirus
por: Wu, Wai-Hong, et al.
Publicado: (2011) -
Measurement of Neutralizing Serum Antibodies of Patients Vaccinated with Human Papillomavirus L1 or L2-Based Immunogens Using Furin-Cleaved HPV Pseudovirions
por: Wang, Joshua W., et al.
Publicado: (2014) -
Impact of Inhibitors and L2 Antibodies upon the Infectivity of Diverse Alpha and Beta Human Papillomavirus Types
por: Kwak, Kihyuck, et al.
Publicado: (2014)